REPORT OF BRAIN TUMOR STATISTICS
IN JAPAN, 1969 JAPAN, -1990 In 1975, the Brain Tumor Registry of Japan was founded to investigate the actual characteristics of brain tumors in Japan. The purpose of this registry is to supply useful information for the development of treatment for brain tumors . Eighty-one professors from neurosurgery departments in the universities and colleges throughout Japan are members of this committee . The Registry (Chairperson; Kintomo Takakura) published its ninth report in 1996, which contained a statistical analysis of 63,438 patients registered from 1969 to 1990 inclusive (Report of the Committee of the Brain Tumor Registry of Japan, 1996, in Japanese). The present paper is an excerpt from that report, presenting data on the frequency and anatomical distribution of brain tumors, patient age and sex, and survival rates as the results of treatment during this period .
Hopefully, this English edition provides internationally valuable information in the field of neuro-oncology to develop successful treatments for brain tumor, especially malignant brain tumor patients, and follows on from the previous English report (Neurologia medico-chirurgica vol. 32. No7. Special issue, 1992) Analysis of case data collected between 1991 and 1993 is still in progress and a report of the results is scheduled for publishing at the beginning of 2000 . For the acquisition of statistics reported herein, 419 institutions were recruited as of 1990, and they were consisting of most universities, colleges, and hospitals with a board authorized by the Japan Neurosurgical Society. Prior to 1983, only universities, colleges, and their affiliate hospitals (247 institutes in total) had been enrolled with the Registry. The investigation was carried out using questionnaire forms including case registration forms, which were sent by the secretariat to all of the above-referenced institutions. The completed registration forms provide information regarding patient birthplace and present residential area, occupation, age, tumor pathology, tumor sites, diagnostic method employed, clinical grade (performance state), therapies (surgery, radiation, chemo-or immunotherapy), and the outcome of these treatments. All registration forms returned to the secretarial were thoroughly reviewed by the editors and then by neurosurgeons at the National Cancer Center Hospital. A follow-up study was conducted prior to the publication of each report presenting the result of analysis of collected data. Cases died within 30 days from the beginning of treatment were excluded for calculation of survival rate. 
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